Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype

Journal of Medical Virology

Volumn 59, Issue 1, 1999, Pages 84-90

  Visse, Bertrand ^a   Huraux, Jean Marie ^a   Fillet, Anne Marie ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

DNA polymerase; Foscarnet; Mutant laboratory; Resistance; Varicella zoster virus

Indexed keywords

FOSCARNET; VIRUS DNA;

AMINO ACID SUBSTITUTION; ARTICLE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CHICKENPOX; CHILD; DNA, VIRAL; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; FOSCARNET; HERPESVIRUS 3, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

EID: 0032799139     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199909)59:1<84::AID-JMV14>3.0.CO;2-N     Document Type: Article

References (27)

1. Baldanti F, Underwood MR, Stanat SC, Biron KK, Chou S, Sarasini A, Silini E, Gerna G. 1996. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistance human cytomegalovirus strains recovered from patients with AIDS. J Virol 78:1390-1395.
2. Balfour HH, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S. 1993. Management of acyclovir-resistance herpes simplex virus and varicella-zoster virus infections. J Acquir Immune Def Syndr 7:254-60.
3. Bendel AE, Gross TG, Woods WG, Edelman CK, Balfour HH. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet 341: 1342.
4. Boivin G, Edelman CK, Pedneault L, Talarico CL, Biron KK, Balfour HH. 1994. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster virus isolated from person with AIDS. J Infect Dis 170:68-75.
5. Coen DM. 1991. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antiviral Res 15:287-300.
6. Crumpacker CS. 1992. Mechanism of action of foscarnet against viral polymerases. Am J Med 92:(S2A); 3S-7S.
7. Davison AJ, Scott JE. 1986. The complete DNA sequence of varicella-zoster virus. J Gen Virol 67:1759-1816.
8. Fillet AM, Visse B, Caumes E, Dumont B, Gentilini M, Huraux JM. 1995. Foscarnet-resistant multidermatomal zoster in a patient with AIDS. Clin Infect Dis 21:1348-1349.
9. Fillet AM, Dumont B, Caumes E, Visse B, Agut H, Bricaire F, Huraux JM. 1998. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization. J Med Virol 55:250-254.
10. Gibbs JS, Chiou HC, Bastow KF, Cheng YC, Coen DM. 1988. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci USA 85:6672-6676.
11. Hwang CBC, Ruffner KL, Coen DM. 1992. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J Virol 66:1774-1776.
12. Jacobson MA, Berger TG, Fikrig S, Becherer P, Moohr J, Stanat SC, Biron KK. 1990. Acyclovir-resistant varicella zoster virus infection after-chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:187-191.
13. Larder BA, Kemp SD, Darby G. 1987. Related functional domains in virus DNA polymerases. EMBO J 6:169-175.
14. Linnemann CC, Biron KK, Hoppenjans WG, Solinger AM. 1990. Emergence of acyclovir-resistant varicella-zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 4:577-579.
15. Lurain NS, Thompson KD, Holmes EW, Sullivan Read G. 1992. Point mutation in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 66:7146-7152.
16. Nicholas J. 1996. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 70:5975-5989.
17. Oberg B. 1983. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Therpeut 19:387-415.
18. Pahwa S, Biron K, Lim W, Swenson P, Kaplan MH, Sadick N, Pahwa R. 1988. Continous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 260:2879-2882.
19. Safrin S, Berger TG, Gilson I, Wolfe PR, Wofsy CB, Mills J, Biron KK. 1991. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med 115:19-21.
20. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad of Sciences USA 74:5463-5467.
21. Snoeck R, Gerard M, Sadzot-Delvaux C, Andrei G, Balzarini J, Reymen D, Piette J, Rentier B, Clumeck N, De Clercq E. 1993. Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDS. J Infect Dis 168:1330-1331.
22. Sullivan V, Biron KK, Talarico C, Stanat SC, Davis M, Pozzi LM, Coen DM. 1993. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxy-alkyl derivatives. Antimicrobrob Agents Chemother 37:19-25.
23. Takayama M, Takayama N, Inoue N, Kameoka Y. 1996. Application of long PCR method to identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol 34:2869-2874.
24. Talarico CL, Phelps WC, Biron KK. 1993. Analysis of the thymidine kinase gene from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J Virol 67:1024-1033.
25. Teo IA, Griffin BE, Jones MD. 1991. Characterization of the DNA polymerase gene of human herpesvirus 6. J Virol 65:4670-4680.
26. Visse B, Dumont B, Huraux JM, Fillet AM. 1998. Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS. J Infect Dis 178:S55-S57.
27. Wong SW, Wahl AF, Yuan PM, Arai N, Pearson BE, Arai K, Korn D, Hunkapiller MW, Wang TSF. 1988. Human DNA polymerase a gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerase. EMBO J 7:37-47.